SBI Mutual Fund is launching the next series of fixed maturity plans (FMP)

Considering the fact that the month of December has been a wonderful month for small-cap stocks, we believe that this trend would continue. Hence, we have curated a list of stocks that might outperform in the month of December. This list is based on BSE Smallcap index.  

Biocon Biologics, a subsidiary of Biocon announced on Friday that the US Court of Appeals for the Federal Circuit (USCAFC) has supported the decisions of the US Patent & Trademark Appeal Board for the unpatentability of five device patents for Sanofi’s Lantus SoloSTAR. The case was filed in April and May 2020. 

Following are the stocks where profit booking is seen taking place in the F&O segment.

List of the futures contracts that are generating the highest as well as the lowest returns for the day.

Brandbucket Media & Technology Limited became the 358^th company to get listed on the BSE SME Platform on December 31, 2021. Brandbucket Media & Technology Limited had come out with an initial public offering of 15,00,000 Equity Shares of Rs. 10 each for cash at a Price of Rs. 55 per equity share , aggregating to Rs. 8.25 crore. The company has successfully completed its public issue on December 23, 2021.

Moreover, it will also invest GBP 25 million as growth capital to accelerate the commercial rollout.   

HCL already owns an 80.4 per cent stake in the company and is buying out the minority partner who holds the balance 19.6 per cent stake in the company. The cost of acquisition is USD 100.2M (Rs 750 crore) for the remaining 19.6 per cent ownership of HCL Technologies SEP Holdings Inc.

On Thursday, the benchmark indices ended on a flat note with Nifty at 17,204 level and Sensex at 57,794 level. In today’s choppy session, good buying interest is seen in selected IT and pharma stocks while some selling pressure is seen in metal and real estate names. 

On Thursday, Sensex and Nifty ended marginally down due to losses in Reliance Industries, Bajaj Finance and Maruti as investors remained cautious amid surging Omicron cases.